Mark W. Pandori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mark W. Pandori has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Abel Wu
San Francisco Department of Public Health Laboratory, San Francisco, California
2 shared publicationsSean Buono
San Francisco Department of Public Health Laboratory, San Francisco, California 94102, USA
2 shared publicationsDavid C. Hess
Santa Clara University
1 shared publicationJeffrey D. Klausner
Division of STD Control and Prevention
1 shared publicationJonathan S. Carlson
San Francisco Department of Public Health Laboratory, San Francisco, California
1 shared publicationKenneth A. Katz
Health and Human Services Agency
1 shared publication
Latest Publications
- 1 October 2012
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 18 (5) , 510-517
Using the Neisseria gonorrhoeae Multiantigen Sequence-Typing Method to Assess Strain Diversity and Antibiotic Resistance in San Francisco, California
Urogenital Neisseria gonorrhoeae isolates (266) collected in San Francisco, CA, in 2009 were analyzed for antimicrobial susceptibility and were subsequently genotyped by N. gonorrhoeae multiantigen sequence typing (NG-MAST). Isolates of identical or closely related sequence types were found to possess highly similar phenotypes with regard to drug susceptibility. Isolates containing decreased susceptibility to oral cephalosporins were detected in 2009 and were found to contain the mosaic penA allele (XXXIV) found previously to be associated with decreased susceptibility to cephalosporins. A better understanding of the relationships between phenotypic and genotypic markers for antimicrobial resistance may be helpful to the development of effective surveillance systems for drug-resistant N. gonorrhoeae .
- 1 October 2012
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 18 (5) , 510-517
Using the Neisseria gonorrhoeae Multiantigen Sequence-Typing Method to Assess Strain Diversity and Antibiotic Resistance in San Francisco, California
Urogenital Neisseria gonorrhoeae isolates (266) collected in San Francisco, CA, in 2009 were analyzed for antimicrobial susceptibility and were subsequently genotyped by N. gonorrhoeae multiantigen sequence typing (NG-MAST). Isolates of identical or closely related sequence types were found to possess highly similar phenotypes with regard to drug susceptibility. Isolates containing decreased susceptibility to oral cephalosporins were detected in 2009 and were found to contain the mosaic penA allele (XXXIV) found previously to be associated with decreased susceptibility to cephalosporins. A better understanding of the relationships between phenotypic and genotypic markers for antimicrobial resistance may be helpful to the development of effective surveillance systems for drug-resistant N. gonorrhoeae .
- 1 August 2011
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 17 (3) , 425-427
Clinical Neisseria gonorrhoeae Isolates in the United States with Resistance to Azithromycin Possess Mutations in All 23S rRNA Alleles and the mtrR Coding Region
We identified strains of Neisseria gonorrhoeae in San Diego County, California, that possess high levels of resistance to azithromycin (8.0–16.0 μg/ml MIC). These isolates contain a combination of mutations in both the 23S rRNA loci and mtrR genes. This is the first description of such isolates in the United States.
- 1 August 2011
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 17 (3) , 425-427
Clinical Neisseria gonorrhoeae Isolates in the United States with Resistance to Azithromycin Possess Mutations in All 23S rRNA Alleles and the mtrR Coding Region
We identified strains of Neisseria gonorrhoeae in San Diego County, California, that possess high levels of resistance to azithromycin (8.0–16.0 μg/ml MIC). These isolates contain a combination of mutations in both the 23S rRNA loci and mtrR genes. This is the first description of such isolates in the United States.